title: Re: The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.
authors: Paola
authors: P
authors: Gazzaniga
authors: Ida
authors: I
authors: Silvestri
authors: Angela
authors: A
authors: Gradilone
authors: Anna Maria
authors: AM
authors: Aglianò
mesh_terms: D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003131:Combined Modality Therapy; D015653:Cystectomy / Q000401:mortality; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D019008:Drug Resistance, Neoplasm; D015251:Epirubicin / Q000009:adverse effects*; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000401:mortality* / Q000628:therapy; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; D003841:Deoxycytidine; D015251:Epirubicin; D000093542:Gemcitabine